These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2581241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Palliative treatment of nonresectable lung cancer by upper hemibody perfusion of chlorimine (short-acting alkylating agent): experience with five cases.
    Sher MH, Trummer MJ, Moquin RB.
    Am Surg; 1966 Jun; 32(6):385-7. PubMed ID: 4160225
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [After care of operated bronchogenic carcinoma with an atoxic antineoplastic agent].
    Hansen JL.
    Ugeskr Laeger; 1975 Jun 23; 137(26):1466-9. PubMed ID: 1096394
    [No Abstract] [Full Text] [Related]

  • 8. [Bronchial arterial cytostatic perfusion of bronchial cancer].
    Schulz V, Weigand H, Ferlinz R.
    Prax Klin Pneumol; 1984 Aug 23; 38(8):356-65. PubMed ID: 6207520
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF, Carr DT, Dhingra HM, Murphy WK, Spitzer G, Umsawasdi T, Bodey GP, Valdivieso M.
    Cancer Treat Rep; 1986 Jun 23; 70(6):795-6. PubMed ID: 3015403
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
    Hoefer H, Scheef W, Titscher R, Kokron O.
    Osterr Z Onkol; 1974 Jun 23; (1):3-7. PubMed ID: 4619650
    [No Abstract] [Full Text] [Related]

  • 12. Some preliminary observations during the phase I clinical testing of cis-dichlorodiammineplatinum. II.
    Fiserová J, Dostálová O, Drobník J, Dohnalová J, Holík F.
    Neoplasma; 1973 Jun 23; 20(2):221-2. PubMed ID: 4707844
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiotherapy of bronchogenic carcinoma.
    Lee RE.
    Semin Oncol; 1974 Sep 23; 1(3):245-52. PubMed ID: 4143487
    [No Abstract] [Full Text] [Related]

  • 15. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P, Lagoudis M, Kostis E.
    J Chemother; 1989 Jul 23; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract] [Full Text] [Related]

  • 16. Panel report. The surgeon's viewpoint on collaborative research on lung cancer.
    Mountain CF.
    Cancer Chemother Rep 3; 1973 Mar 23; 4(2):307-9. PubMed ID: 4125745
    [No Abstract] [Full Text] [Related]

  • 17. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS, Birch R, Greco A, Prestridge K, Johnson R.
    Cancer Treat Rep; 1986 Aug 23; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract] [Full Text] [Related]

  • 18. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
    Sculier JP.
    Rev Mal Respir; 1993 Aug 23; 10(4):287-9. PubMed ID: 8235020
    [No Abstract] [Full Text] [Related]

  • 19. Panel report. Interdisciplinary group on clinical trials (biostatistics).
    Zelen M.
    Cancer Chemother Rep 3; 1973 Mar 23; 4(2):317-9. PubMed ID: 4580859
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.